Path-Organism Burden and Antibiogram Outline of Pseudomonas aeruginosa Isolates in a Tertiary Care Hospital of Jamshedpur, Jharkhand, India

Abstract

Mohammad Mustaqueem1, Vindeshwar Mahto2, Chandan Kumar Poddar3, Rita Chouhan4, Prity Mohan Kumar5, M.N. Singh6

BACKGROUND
Pseudomonas aeruginosa is an opportunistic pathogen involved in a variety of
nosocomial infections like pneumonia, bacteraemia, wound infection and urinary
tract infection. It is also involved in infections of rigorous burns and infections in
immunocompromised persons. This study was undertaken to determine the
prevalence and antibiotic susceptibility patterns of pathogenic P. aeruginosa
isolated from a variety of clinical specimens in a tertiary care hospital of
Jamshedpur, Jharkhand, India.
METHODS
Pseudomonas aeruginosa was identified using standard methods from various
clinical samples collected over a period of seven months. This was a descriptive
cross-sectional study which was approved by the ethical committee. The study
was conducted from January 2019 to January 2020 in the Department of
Microbiology at MGM Medical College, Jamshedpur, Jharkhand, India. This hospital
has ICUs, one emergency ward, surgical & medical wards and Out-Patient
Departments.
RESULTS
Our study showed the prevalence of P. aeruginosa during the study period from
January 2019 to January 2020 in the Department of Microbiology at MGM Medical
College, Jamshedpur, Jharkhand, India. A total of 1389 clinical samples were
aerobically cultured, out of which 758 (54.6 %) yielded significant growth and the
rest 630 (45.4 %) samples were either sterile or showed non-significant growth.
From 758 positive growth samples, 161 (21.20 %) P. aeruginosa were isolated.
CONCLUSIONS
The high prevalence of P. aeruginosa as an opportunistic nosocomial pathogen
and high frequency of antimicrobial resistance among the clinical isolates demand
regular monitoring of antibiogram of P. aeruginosa isolates with proper
implementation of antimicrobial policy. Antibiotics should be used appropriately
with care. Antimicrobial therapy should not be started unless there is clear
evidence of infection and infection to be handled with proper infection control
measures.

image